Suster S, Rywlin A M
Cancer. 1987 Apr 15;59(8):1412-8. doi: 10.1002/1097-0142(19870415)59:8<1412::aid-cncr2820590806>3.0.co;2-c.
Richter's syndrome, the development of a malignant lymphoma in a patient with preexisting chronic lymphocytic leukemia (CLL) is an infrequent but well-documented phenomenon generally thought to represent a monoclonal proliferation of B-lymphocytes arising from the CLL. A heterogeneous population of cells consisting of sheets of transformed lymphocytes in combination with clusters of bizarre, atypical histiocytes developed in a patient with a history of longstanding CLL. Immunocytochemistry using a panel of monoclonal and polyclonal antibodies by immunoperoxidase techniques identified the presence of both B-lymphocytic and monocytic-histiocytic cell lines of differentiation. A mechanism of multiple differentiation is proposed to account for the dual cell population observed in this patient. Review of the literature appears to indicate that this phenomenon often may be involved in cases diagnosed as Richter's syndrome. The demonstration of cellular heterogeneity in the current case underscores the need for establishing a more precise definition for the histologic characterization of the terminal malignancy in Richter's syndrome.
里氏综合征,即在已有慢性淋巴细胞白血病(CLL)的患者中发生恶性淋巴瘤,是一种罕见但有充分文献记载的现象,一般认为它代表源自CLL的B淋巴细胞的单克隆增殖。一名有长期CLL病史的患者体内出现了由成片转化淋巴细胞与奇异、非典型组织细胞簇组成的异质性细胞群。通过免疫过氧化物酶技术使用一组单克隆和多克隆抗体进行免疫细胞化学检测,确定存在B淋巴细胞和单核组织细胞分化细胞系。有人提出一种多分化机制来解释该患者中观察到的双细胞群现象。文献回顾似乎表明,这种现象在诊断为里氏综合征的病例中可能经常出现。当前病例中细胞异质性的证明强调了为里氏综合征终末期恶性肿瘤的组织学特征建立更精确定义的必要性。